Clinical Context
We think this might be relevant to the clinical guidance for CLL-IPI (Chronic Lymphocytic Leukemia).
Clinical Context
We think this might be relevant to the clinical guidance for CLL-IPI (Chronic Lymphocytic Leukemia).
Clinical Context
We think this might be relevant to the clinical guidance for CLL-IPI (Chronic Lymphocytic Leukemia).
CLL-IPI: Validated prognostic index for treatment-naive CLL. Integrates genetic, biochemical, and clinical markers to predict 5-year survival.
CLL-IPI Total Score
Risk Category
93.2% 5-year Survival
Active surveillance ('Watch and Wait') is typically appropriate unless symptomatic.
Verified
Last Review: 2026
Last Comprehensive Review: 2026
